Radiolabelling of TiO2 nanoparticles for radiotracer studies

被引:32
作者
Abbas, Kamel [1 ]
Cydzik, Izabela [1 ]
Del Torchio, Riccardo [1 ]
Farina, Massimo [1 ]
Forti, Efrat [1 ]
Gibson, Neil [1 ]
Holzwarth, Uwe [1 ]
Simonelli, Federica [1 ]
Kreyling, Wolfgang [2 ]
机构
[1] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect TP 500, I-21027 Ispra, VA, Italy
[2] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Muenchen, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-85764 Neuherberg, Germany
关键词
Nanoparticles; Radiolabelling; Titanium dioxide; In vitro; Cell uptake; Nanomanufacturing; Nanomedicine; CARBON NANOTUBES; MANUFACTURED NANOPARTICLES; ULTRAFINE PARTICLES; CELL LINES; NANOTECHNOLOGY; NANOMATERIALS; ENVIRONMENT; DELIVERY; CULTURE; WORKERS;
D O I
10.1007/s11051-009-9806-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Industrially manufactured titanium dioxide nanoparticles have been successfully radiolabelled with V-48 by irradiation with a cyclotron-generated proton beam. Centrifugation tests showed that the V-48 radiolabels were stably bound within the nanoparticle structure in an aqueous medium, while X-ray diffraction indicated that no major structural modifications to the nanoparticles resulted from the proton irradiation. In vitro tests of the uptake of cold and radiolabelled nanoparticles using the human cell line Calu-3 showed no significant difference in the uptake between both batches of nanoparticles. The uptake was quantified by Inductively Coupled Plasma Mass Spectrometry and high resolution gamma-ray spectrometry for cold and radiolabelled nanoparticles, respectively. These preliminary results indicate that alterations to the nanoparticles' properties introduced by proton bombardment can be controlled to a sufficient extent that their further use as radiotracers for biological investigations can be envisaged and elaborated.
引用
收藏
页码:2435 / 2443
页数:9
相关论文
共 33 条
[1]   Manufacture and use of nanomaterials: current status in the UK and global trends [J].
Aitken, R. J. ;
Chaudhry, M. Q. ;
Boxall, A. B. A. ;
Hull, M. .
OCCUPATIONAL MEDICINE-OXFORD, 2006, 56 (05) :300-306
[2]   Nanoparticles and nanolayers in commercial applications [J].
Anselmann, R .
JOURNAL OF NANOPARTICLE RESEARCH, 2001, 3 (04) :329-336
[3]   Protecting workers and the environment: An environmental NGO's perspective on nanotechnology [J].
Balbus, John M. ;
Florini, Karen ;
Denison, Richard A. ;
Walsh, Scott A. .
JOURNAL OF NANOPARTICLE RESEARCH, 2007, 9 (01) :11-22
[4]   Respiratory carcinoma cell lines -: MUC genes and glycoconjugates [J].
Berger, JT ;
Voynow, JA ;
Peters, KW ;
Rose, MC .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (03) :500-510
[5]  
Di Giampaolo L, 2004, Int J Immunopathol Pharmacol, V17, P115
[6]  
Di Gioacchino M, 2007, Int J Immunopathol Pharmacol, V20, P15
[7]   Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas [J].
Florence, AT ;
Hussain, N .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S69-S89
[8]  
Forbes Ben, 2000, Pharmaceutical Science and Technology Today, V3, P18, DOI 10.1016/S1461-5347(99)00231-X
[9]   ABNORMALITIES OF PULMONARY-FUNCTION AND PLEURAL DISEASE AMONG TITANIUM METAL PRODUCTION WORKERS [J].
GARABRANT, DH ;
FINE, LJ ;
OLIVER, C ;
BERNSTEIN, L ;
PETERS, JM .
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 1987, 13 (01) :47-51
[10]   Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier [J].
Grainger, Christopher I. ;
Greenwell, Leona L. ;
Lockley, David J. ;
Martin, Gary P. ;
Forbes, Ben .
PHARMACEUTICAL RESEARCH, 2006, 23 (07) :1482-1490